LEXINGTON, Mass.--(BUSINESS WIRE)--May 14, 2019--
Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will
participate at the following upcoming investor conferences:
- The UBS Global Healthcare Conference on May 21, 2019 at 10:00 a.m. ET
in New York, NY;
The Jefferies 2019 Global Healthcare Conference on June 5, 2019 at
10:30 a.m. ET in New York, NY; and
- The JMP Securities Life Sciences Conference on June 19, 2019 at 9:00
a.m. ET in New York, NY.
Live webcasts of the presentations may be accessed in the Investors
section of the Company’s website at www.concertpharma.com.
Please log on to the Concert website approximately 15 minutes prior to
the scheduled webcast to ensure adequate time for any software downloads
that may be required. A replay of the conference webcasts will be
available on Concert’s website for two weeks following the presentations.
Pharmaceuticals is a clinical stage biopharmaceutical company
focused on applying its DCE
Platform® (deuterated chemical entity platform) to create novel
medicines designed to treat serious diseases and address unmet patient
needs. The Company’s approach starts with previously studied compounds,
including approved drugs, in which deuterium substitution has the
potential to enhance clinical safety, tolerability or efficacy.
Concert’s pipeline of
innovative medicines targets autoimmune diseases and central nervous
systems (CNS) disorders. For more information please visit www.concertpharma.com
or follow us on Twitter at @ConcertPharma
or on LinkedIn.
Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and
DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190514005115/en/
Source: Concert Pharmaceuticals, Inc.